Tempo Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Tempo Therapeutics?

Tempo Therapeutics has 5 investors including Ajax Capital And Johnson & Johnson Services, Inc..

Q: How much funding has Tempo Therapeutics raised to date?

Tempo Therapeutics has raised obfuscated.

Overview

Tempo Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Tempo Therapeutics

CB Rank

58372

Tempo Therapeutics develops materials that are immune stealth, minimally invasive, and precision-engineered for regenerative medicine.

Founded

obfuscation

Private

Venture - Series Unknown

San Diego, California, United States

1-10

tempothera.com/

Health Care

Medical

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Westbrook Weaver: Founder and CEO
Dino Di Carlo: Co-founder and Board Member
Past Role: Vortex Biosciences, Co-founder and Board Member

Details

Legal Name

Tempo Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Dino Di Carlo, Westbrook Weaver

About the Company

Tempo Therapeutics develops materials that are immune stealth, minimally invasive, and precision-engineered for regenerative medicine. It provides power to regenerative medicine, providing materials that evade the typical host immune rejection response to build synthetic tissue hybrids from skin to bone to heart to brain.

Predictions & Insights

Growth Insight

See this Growth Insight

Tempo Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

MAP Technology

A microporous annealed particle scaffold platform that supports tissue regeneration by modulating immune response and enabling tissue growth.

TT101

A tissue repair product based on MAP technology designed for use in skin cancer surgery to aid tissue regeneration.

Research & Development

Tempo Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Tempo Therapeutics	2	obfuscated obfuscation	Johnson & Johnson Services, Inc.	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tempo Therapeutics	2	obfuscated obfuscation	Johnson & Johnson Services, Inc.	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tempo Therapeutics	2	obfuscated obfuscation	Johnson & Johnson Services, Inc.	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tempo Therapeutics	2	obfuscated obfuscation	Johnson & Johnson Services, Inc.	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tempo Therapeutics	2	obfuscated obfuscation	Johnson & Johnson Services, Inc.	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Tempo Therapeutics	2	obfuscated obfuscation	Johnson & Johnson Services, Inc.	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tempo Therapeutics	2	obfuscated obfuscation	Johnson & Johnson Services, Inc.	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tempo Therapeutics	2	obfuscated obfuscation	Johnson & Johnson Services, Inc.	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tempo Therapeutics	2	obfuscated obfuscation	Johnson & Johnson Services, Inc.	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Tempo Therapeutics	2	obfuscated obfuscation	Johnson & Johnson Services, Inc.	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Ajax Capital	—	Venture Round - Tempo Therapeutics	—
Ajax Capital	—	Venture Round - Tempo Therapeutics	—
Ajax Capital	—	Venture Round - Tempo Therapeutics	—
Ajax Capital	—	Venture Round - Tempo Therapeutics	—
Ajax Capital	—	Venture Round - Tempo Therapeutics	—